HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Normanno Selected Research

Carcinoma (Carcinomatosis)

5/2005The ErbB receptors and their ligands in cancer: an overview.
3/2003Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
5/2001The role of EGF-related peptides in tumor growth.
11/2000Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.
4/2000Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
3/2000EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Normanno Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 04/2000
8Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 11/2012
7Breast Neoplasms (Breast Cancer)
08/2012 - 01/2002
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 07/2010
6Carcinoma (Carcinomatosis)
05/2005 - 03/2000
3Circulating Neoplastic Cells
01/2021 - 04/2000
2Neoplasm Metastasis (Metastasis)
03/2012 - 06/2005
2Pain (Aches)
09/2010 - 06/2005
1Disease Progression
01/2022
1Cholangiocarcinoma
01/2021
1Vulvar Neoplasms (Vulvar Cancer)
11/2020
1Thyroid Neoplasms (Thyroid Cancer)
11/2020
1Lung Neoplasms (Lung Cancer)
11/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2020
1Overweight
08/2012
1Hemorrhage
01/2012
1Melanoma (Melanoma, Malignant)
09/2011
1medullary Thyroid cancer
09/2010
1Leiomyoma (Uterine Fibroids)
01/2007
1Leiomyosarcoma
01/2007
1Bone Diseases (Bone Disease)
06/2005

Drug/Important Bio-Agent (IBA)

13ErbB Receptors (EGF Receptor)IBA
10/2023 - 04/2000
7Cetuximab (Erbitux)FDA Link
01/2023 - 09/2014
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2011 - 03/2000
6Proteins (Proteins, Gene)FDA Link
09/2011 - 03/2000
6Epidermal Growth Factor (EGF)IBA
05/2005 - 03/2000
5Peptides (Polypeptides)IBA
05/2005 - 03/2000
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2002
3Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2010
3Monoclonal AntibodiesIBA
09/2014 - 01/2002
3Tyrosine Kinase InhibitorsIBA
07/2010 - 01/2002
3LigandsIBA
07/2010 - 03/2003
3Gefitinib (Iressa)FDA Link
10/2005 - 01/2002
3Trastuzumab (Herceptin)FDA Link
10/2005 - 01/2002
2Irinotecan (Camptosar)FDA LinkGeneric
01/2023 - 01/2016
2Circulating Tumor DNAIBA
01/2023 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2021
2Zoledronic Acid (Zometa)FDA Link
08/2012 - 03/2012
2Messenger RNA (mRNA)IBA
09/2011 - 04/2000
2Docetaxel (Taxotere)FDA Link
09/2010 - 05/2006
2Phosphotransferases (Kinase)IBA
09/2010 - 05/2005
2Tyrosine (L-Tyrosine)FDA Link
09/2010 - 05/2005
2Transforming Growth Factor alpha (TGF-alpha)IBA
11/2000 - 03/2000
2AmphiregulinIBA
11/2000 - 03/2000
1avelumabIBA
01/2023
1ivosidenibIBA
01/2022
1infigratinibIBA
01/2022
1pemigatinibIBA
01/2022
1CytokinesIBA
11/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1pembrolizumabIBA
11/2020
1AntibodiesIBA
11/2020
1Leucovorin (Folinic Acid)FDA Link
01/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016
1Fluorouracil (Carac)FDA LinkGeneric
01/2016
1Growth Factor ReceptorsIBA
09/2014
1Formaldehyde (Formol)FDA Link
11/2012
1Letrozole (Femara)FDA LinkGeneric
08/2012
1Hormones (Hormone)IBA
08/2012
1AcidsIBA
08/2012
1Triptorelin Pamoate (Trelstar)FDA Link
08/2012
1TamoxifenFDA LinkGeneric
08/2012
1Conditioned Culture MediaIBA
03/2012
1Estrogen ReceptorsIBA
03/2012
1Bevacizumab (Avastin)FDA Link
01/2012
1saracatinibIBA
09/2011
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
09/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2010
1Pemetrexed (MTA)FDA Link
09/2010
1vandetanib (ZD6474)IBA
09/2010
1Glycogen Synthase Kinase 3 betaIBA
01/2007
1beta CateninIBA
01/2007
1AnthracyclinesIBA
05/2006
1Epirubicin (Ellence)FDA LinkGeneric
05/2006
1Taxoids (Taxanes)IBA
05/2006
1OligonucleotidesIBA
11/2000
1Keratin-19 (Keratin 19)IBA
04/2000
1Carcinoembryonic AntigenIBA
04/2000
1Antisense OligonucleotidesIBA
03/2000
1Cisplatin (Platino)FDA LinkGeneric
03/2000
1Paclitaxel (Taxol)FDA LinkGeneric
03/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2000

Therapy/Procedure

6Therapeutics
01/2023 - 05/2006
4Precision Medicine
01/2022 - 01/2018
4Drug Therapy (Chemotherapy)
01/2021 - 05/2006
2Investigational Therapies (Experimental Therapy)
11/2000 - 03/2000
1Immunotherapy
11/2021
1Neoadjuvant Therapy
05/2006
1Aftercare (After-Treatment)
03/2000